Compare PLAY & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLAY | EMBC |
|---|---|---|
| Founded | 1982 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.3M | 354.1M |
| IPO Year | 2011 | 2021 |
| Metric | PLAY | EMBC |
|---|---|---|
| Price | $8.30 | $6.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | ★ $13.00 | $4.00 |
| AVG Volume (30 Days) | ★ 1.9M | 800.4K |
| Earning Date | 12-08-2026 | 11-24-2026 |
| Dividend Yield | N/A | ★ 0.65% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.11 | $5.59 |
| P/E Ratio | ★ N/A | $6.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.26 | $2.77 |
| 52 Week High | $22.10 | $14.91 |
| Indicator | PLAY | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 55.36 | 53.84 |
| Support Level | $6.50 | $3.01 |
| Resistance Level | $8.62 | $6.90 |
| Average True Range (ATR) | 0.62 | 0.33 |
| MACD | 0.08 | -0.06 |
| Stochastic Oscillator | 63.56 | 53.12 |
Dave & Buster's Entertainment Inc is an owner and operator of entertainment and dining venues in North America that offer experiences for both adults and families under the Dave & Buster's and Main Event brands. The company combines various forms of entertainment, including games, bowling, and watching live sports and other televised events, with a full menu of entrees and appetizers and a selection of alcoholic and non alcoholic beverages, all in one location. Its concept focuses on providing customers the opportunity to Eat, Drink, Play, and Watch, appealing to a balanced mix of adults, families, and teenagers. The company also operates internationally in the early stage as a franchisor of the Dave & Buster's brand.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.